Medicine and Dentistry
Myeloid Leukemia
100%
Non-Homologous End Joining
66%
Leukemia Cell
56%
Gene
46%
Myelodysplastic Syndrome
43%
DNA Damage
33%
PARP Inhibitor
33%
Heterodimer
33%
Myeloid Malignancy
33%
Reactive Oxygen Species
33%
Protein
33%
Histone Deacetylase Inhibitor
33%
DNA
33%
DNA Repair
33%
Induced Mutation
33%
Hypersensitivity
33%
Disease Exacerbation
26%
Assay
23%
Therapeutic Procedure
20%
Acute Myeloid Leukemia
20%
In Vitro
13%
Ligation
13%
Chromosome Aberration
13%
Cells
13%
Homologous Recombination
13%
Chromosomal Instability
13%
Patient
10%
Element
6%
Donor
6%
Pimethixene
6%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
6%
Transgenic Mouse
6%
Disease
6%
Antioxidant
6%
Progenitor Cell
6%
DNA Mismatch Repair
6%
RNA Interference
6%
Bone Marrow
6%
Mononuclear Cell
6%
Acute Myeloid Leukemia Cell Line
6%
Hematopoietic Cell
6%
Tumor Progression
6%
Incidence
6%
Tumor Initiation
6%
Rodent Cell
6%
Mutant
6%
Biochemistry, Genetics and Molecular Biology
Genome Instability
66%
Gene
63%
Chromosome Instability
43%
Ku70
41%
Reduction (Chemistry)
41%
Bloom Syndrome
33%
Loss of Heterozygosity
33%
Chromatid
26%
Chromosomal Abnormalities
26%
Karyotype
19%
RAC1
16%
Replication Protein
11%
Oncogene
11%
Centromere
11%
Origin of Replication
11%
Wild Type
9%
Hematopoiesis
8%
Mammalian Cell
8%
Chromosomal Rearrangement
8%
NAD(P)H Oxidase
8%
Helicase
8%
Mouse Model
8%
Chromosome Abnormality
6%
